Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Kasabach-Merritt syndrome.

R F Maceyko¹, C Camisa

¹Department of Dermatology, Cleveland Clinic Foundation, Ohio 44195-5032.

Pediatric Dermatology

|June 1, 1991

Summary

Kasabach-Merritt syndrome, a rare condition involving vascular tumors and low platelet counts, can cause life-threatening bleeding. This case highlights the complex management challenges associated with this syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intertriginous bullae in a 53-year-old man.

Archives of dermatology·2001

Same author

Effective treatment of oral erosive lichen planus with thalidomide.

Archives of dermatology·2000

Same author

Paraneoplastic pemphigus: a review of the literature.

Oral diseases·2000

Same author

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Journal of the American Academy of Dermatology·2000

Same author

Psoriasis: a clinical update on diagnosis and new therapies.

Cleveland Clinic journal of medicine·2000

Same author

Cicatrizing conjunctivitis associated with paraneoplastic lichen planus.

American journal of ophthalmology·2000

Area of Science:

Pediatric Hematology
Vascular Anomalies
Coagulation Disorders

Background:

Kasabach-Merritt syndrome (KMS) is characterized by a triad of vascular tumors, thrombocytopenia, and coagulopathy.
While vascular tumors in KMS are typically benign, the associated bleeding disorder poses significant risks.

Observation:

Presents a clinical case illustrating the diagnostic and therapeutic complexities of KMS.
Highlights the potential difficulties encountered in managing patients with this rare syndrome.

Findings:

The case underscores the critical interplay between vascular tumor burden and hemostatic abnormalities.
Demonstrates the challenges in achieving effective platelet count normalization and hemorrhage control.

Implications:

Emphasizes the need for multidisciplinary management strategies for Kasabach-Merritt syndrome.
Suggests that early recognition and tailored interventions are crucial for improving patient outcomes in KMS.

Related Experiment Videos